FEDERATED HERMES, INC. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$347,678
+17283.9%
80,481
+26115.3%
0.00%
Q3 2022$2,000
-99.8%
307
-99.8%
0.00%
-100.0%
Q2 2022$1,284,000
-4.3%
127,797
+18.0%
0.00%0.0%
Q1 2022$1,341,000
+120.6%
108,301
+307.4%
0.00%
+200.0%
Q4 2021$608,000
-62.8%
26,585
-64.0%
0.00%
-66.7%
Q3 2021$1,634,000
-21.0%
73,816
-53.7%
0.00%
-25.0%
Q2 2021$2,068,000
+23.2%
159,526
+23.5%
0.00%
+33.3%
Q1 2021$1,678,000
+6.3%
129,208
+13.3%
0.00%0.0%
Q4 2020$1,578,000
+1.1%
114,032
+7.6%
0.00%
-25.0%
Q3 2020$1,561,000106,0170.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders